CXC Chemokines in Cancer Angiogenesis and Metastases

被引:211
作者
Keeley, Ellen C. [1 ]
Mehrad, Borna [2 ]
Strieter, Robert M. [2 ]
机构
[1] Univ Virginia, Dept Med, Div Cardiol, Charlottesville, VA 22903 USA
[2] Univ Virginia, Dept Med, Div Pulm & Crit Care Med, Charlottesville, VA USA
来源
ADVANCES IN CANCER RESEARCH, VOL 106 | 2010年 / 106卷
关键词
CELL LUNG-CANCER; MICROVASCULAR ENDOTHELIAL-CELLS; DEPENDENT ANTITUMOR RESPONSES; LIGAND BIOLOGICAL AXIS; NONSMALL CELL; RECEPTOR CXCR4; TUMOR-GROWTH; IN-VIVO; BONE-MARROW; HEMATOPOIETIC PROGENITOR;
D O I
10.1016/S0065-230X(10)06003-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The tumor microenvironment is extremely complex that depends on tumor cell interaction with the responding host cells. Angiogenesis, or new blood vessel growth from preexisting vasculature, is a preeminent feature of successful tumor growth of all solid tumors. While a number of factors produced by both the tumor cells and host responding cells have been discovered that regulate angiogenesis, increasing evidence is growing to support the important role of CXC chemokines in this process. As a family of cytokines, the CXC chemokines are pleiotropic in their ability to regulate tumor-associated angiogenesis, as well as cancer cell metastases. In this chapter, we will discuss the disparate activity that CXC chemokines play in regulating cancer-associated angiogenesis and metastases.
引用
收藏
页码:91 / 111
页数:21
相关论文
共 121 条
  • [1] The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity
    Addison, CL
    Daniel, TO
    Burdick, MD
    Liu, H
    Ehlert, JE
    Xue, YY
    Buechi, L
    Walz, A
    Richmond, A
    Strieter, RM
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 165 (09) : 5269 - 5277
  • [2] Overexpression of the duffy antigen receptor for chemokines (DARC) by NSCLC tumor cells results in increased tumor necrosis
    Addison, CL
    Belperio, JA
    Burdick, MD
    Strieter, RM
    [J]. BMC CANCER, 2004, 4 (1)
  • [3] Prognostic Significance of CXCL12 Expression in Patients With Colorectal Carcinoma
    Akishima-Fukasawa, Yuri
    Nakanishi, Yukihiro
    Ino, Yoshinori
    Moriya, Yoshihiro
    Kanai, Yae
    Hirohashi, Setsuo
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2009, 132 (02) : 202 - 210
  • [4] Arenberg D. A., 1995, Journal of Investigative Medicine, V43, p479A
  • [5] Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer
    Arenberg, DA
    Keane, MP
    DiGiovine, B
    Kunkel, SL
    Morris, SB
    Xue, YY
    Burdick, MD
    Glass, MC
    Iannettoni, MD
    Strieter, RM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (03) : 465 - 472
  • [6] Bachelder RE, 2002, CANCER RES, V62, P7203
  • [7] The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes
    Balabanian, K
    Lagane, B
    Infantino, S
    Chow, KYC
    Harriague, J
    Moepps, B
    Arenzana-Seisdedos, F
    Thelen, M
    Bachelerie, F
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (42) : 35760 - 35766
  • [8] Understanding the immunoangiostatic CXC chemokine network
    Balestrieri, Maria Luisa
    Balestrieri, Antonio
    Mancini, Francesco Paolo
    Napoli, Claudio
    [J]. CARDIOVASCULAR RESEARCH, 2008, 78 (02) : 250 - 256
  • [9] The SDF-1/CXCL 12/CXCR4 biological axis in non-small cell lung cancer metastases
    Belperio, JA
    Phillips, RJ
    Burdick, MD
    Lutz, M
    Keane, M
    Strieter, R
    [J]. CHEST, 2004, 125 (05) : 156S - 156S
  • [10] Site-specific metastasis formation Chemokines as regulators of tumor cell adhesion, motility and invasion
    Ben-Baruch, Adit
    [J]. CELL ADHESION & MIGRATION, 2009, 3 (04) : 328 - 333